J9289 Injection nivolumab 2 milligrams hyaluron
J-Codes
Also known as: nivolumab hyaluronidase, Opdivo subcutaneous
Injection of nivolumab combined with hyaluronidase, 2 milligram. A PD-1 checkpoint inhibitor with enhanced subcutaneous delivery formulation.
Clinical Context
Subcutaneous formulation of nivolumab used for melanoma, non-small cell lung cancer, renal cell carcinoma, and other malignancies.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.